Behavioral
Practice Associates Medical Group
Practice Associates Medical Group was paid $49.14M by Medicaid between Jan 2018 and Dec 2024, across 242 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoPRACTICE ASSOCIATES MEDICAL GROUP
MORRISTOWN, NJ 07960
MORRISTOWN, NJ 07960
33aNPI1427016385assigned 05/02/2006
33bProvider typeSocial Worker
28Total paid$49.14M
24GClaims1,145,594
24DCodes billed242
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Social Worker providers in New Jersey
Rank by total paid#1 of 28
Median peer was paid$294K
This provider vs. median167×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 81,154 | $4.05M | |
| 2019 | 105,282 | $5.15M | |
| 2020 | 94,690 | $4.50M | |
| 2021 | 144,756 | $7.48M | |
| 2022 | 229,704 | $9.23M | |
| 2023 | 275,665 | $10.85M | |
| 2024incomplete | 214,343 | $7.88M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 268,869 | 237,755 | $16.03M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 257,191 | 227,330 | $13.35M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.7% | 37,923 | 34,556 | $3.29M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.9% | 55,757 | 22,929 | $1.44M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.8% | 18,221 | 16,909 | $1.38M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.8% | 65,239 | 25,964 | $1.36M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.7% | 24,247 | 20,868 | $1.30M |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 2.1% | 7,159 | 7,111 | $1.02M |
| 99223 | Prolong inpt eval add15 m | 1.5% | 15,174 | 12,885 | $726K |
| 20610 | 1.0% | 10,364 | 6,790 | $504K | |
| 31231 | 1.0% | 5,670 | 5,082 | $499K | |
| 93000 | <1% | 30,401 | 27,899 | $484K |
230 more codes
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,385 | $449K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 4,347 | $405K |
| 99243 | <1% | 3,311 | $368K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 9,650 | $358K |
| 64483 | <1% | 1,658 | $332K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 23,849 | $319K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 8,010 | $302K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 6,952 | $239K |
| 99205 | Prolong outpt/office vis | <1% | 2,367 | $217K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 528 | $200K |
| 31579 | <1% | 1,419 | $200K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 31,426 | $186K |
| 94060 | <1% | 6,790 | $184K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 7,432 | $177K |
| 20611 | <1% | 2,660 | $177K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 9,731 | $172K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 2,004 | $170K |
| 69210 | <1% | 6,417 | $163K | |
| 97803 | <1% | 5,700 | $157K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 11,787 | $150K |
| 95800 | <1% | 3,494 | $139K | |
| 64484 | <1% | 1,397 | $134K | |
| 99460 | <1% | 1,647 | $132K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 2,707 | $131K |
| 95886 | <1% | 1,116 | $96K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,875 | $96K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,555 | $82K |
| 62323 | <1% | 465 | $80K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,914 | $71K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 375 | $70K |
| 99245 | <1% | 493 | $70K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,719 | $68K |
| 90682 | <1% | 1,766 | $65K | |
| 97802 | <1% | 1,375 | $63K | |
| 73562 | <1% | 2,957 | $62K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 933 | $62K |
| 43775 | <1% | 106 | $57K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,428 | $56K |
| 73564 | <1% | 2,283 | $52K | |
| 75574 | <1% | 780 | $51K | |
| 90674 | <1% | 2,601 | $50K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 920 | $50K |
| 31575 | <1% | 544 | $48K | |
| 93298 | <1% | 2,745 | $45K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 8,010 | $40K |
| 51701 | <1% | 768 | $35K | |
| 64615 | <1% | 393 | $33K | |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | <1% | 1,629 | $33K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,805 | $28K |
| 87428 | <1% | 678 | $28K | |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | <1% | 198 | $25K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 91 | $24K |
| 99220 | <1% | 491 | $24K | |
| 73630 | <1% | 1,210 | $22K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 370 | $19K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,282 | $19K |
| 90677 | <1% | 140 | $19K | |
| 73610 | <1% | 899 | $18K | |
| 51798 | <1% | 1,228 | $18K | |
| 81025 | <1% | 3,123 | $17K | |
| 20550 | <1% | 479 | $16K | |
| 64721 | <1% | 46 | $16K | |
| 46600 | <1% | 363 | $16K | |
| 20552 | <1% | 446 | $16K | |
| 99442 | <1% | 1,116 | $16K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 292 | $15K |
| 99385 | <1% | 214 | $15K | |
| 99386 | <1% | 171 | $14K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 3,440 | $14K |
| 99497 | <1% | 394 | $14K | |
| 90686 | <1% | 1,565 | $13K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,061 | $12K |
| 45300 | <1% | 223 | $12K | |
| 93016 | <1% | 1,214 | $11K | |
| 99307 | <1% | 1,684 | $11K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 2,011 | $11K |
| 73560 | <1% | 496 | $11K | |
| 72100 | <1% | 402 | $10K | |
| 99242 | <1% | 97 | $10K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 315 | $10K |
| 77427 | <1% | 75 | $10K | |
| 98929 | <1% | 263 | $10K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 687 | $9K |
| 99221 | <1% | 309 | $9K | |
| 72170 | <1% | 563 | $9K | |
| 93018 | <1% | 371 | $9K | |
| 73030 | <1% | 455 | $8K | |
| 95909 | <1% | 80 | $8K | |
| 94010 | <1% | 726 | $8K | |
| 54161 | <1% | 59 | $8K | |
| 25600 | <1% | 25 | $8K | |
| 47562 | <1% | 12 | $7K | |
| 95251 | <1% | 466 | $7K | |
| 90673 | <1% | 228 | $7K | |
| 81003 | <1% | 8,563 | $7K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 115 | $7K |
| 96112 | <1% | 74 | $6K | |
| 90670 | <1% | 465 | $6K | |
| 62321 | <1% | 33 | $6K | |
| 75561 | <1% | 62 | $6K | |
| 76942 | <1% | 141 | $6K | |
| 81001 | <1% | 1,996 | $6K | |
| 98928 | <1% | 175 | $5K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 245 | $5K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 47 | $5K |
| 73600 | <1% | 305 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 381 | $4K |
| 73110 | <1% | 206 | $4K | |
| 81002 | <1% | 3,474 | $4K | |
| 99217 | <1% | 110 | $4K | |
| 77014 | <1% | 63 | $4K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 67 | $4K |
| 90461 | <1% | 186 | $3K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 90 | $3K |
| 90651 | <1% | 12 | $3K | |
| 99305 | <1% | 112 | $3K | |
| 93325 | <1% | 578 | $3K | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 378 | $3K |
| 54162 | <1% | 37 | $3K | |
| 0031A | <1% | 96 | $3K | |
| 94729 | <1% | 176 | $3K | |
| 91200 | <1% | 105 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 40 | $3K |
| 99401 | <1% | 100 | $3K | |
| 96111 | <1% | 28 | $3K | |
| 90697 | <1% | 35 | $3K | |
| 99441 | <1% | 558 | $2K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 13 | $2K |
| 99462 | <1% | 83 | $2K | |
| 90688 | <1% | 134 | $2K | |
| 73502 | <1% | 127 | $2K | |
| 90661 | <1% | 198 | $2K | |
| 90839 | <1% | 219 | $2K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 280 | $2K |
| 93970 | <1% | 87 | $2K | |
| 93320 | <1% | 135 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,281 | $2K |
| 95911 | <1% | 15 | $2K | |
| 93297 | <1% | 122 | $2K | |
| 94664 | <1% | 218 | $2K | |
| 95910 | <1% | 14 | $2K | |
| 77334 | <1% | 20 | $2K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 156 | $2K |
| 90662 | <1% | 207 | $2K | |
| 95782 | <1% | 16 | $2K | |
| 51702 | <1% | 31 | $2K | |
| 36410 | <1% | 142 | $2K | |
| 96040 | <1% | 159 | $2K | |
| 96127 | <1% | 316 | $2K | |
| 99493 | <1% | 115 | $2K | |
| 99443 | <1% | 62 | $1K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 208 | $1K |
| 72114 | <1% | 46 | $1K | |
| 90671 | <1% | 17 | $1K | |
| 77002 | <1% | 119 | $1K | |
| 59025 | Fetal non-stress test | <1% | 32 | $1K |
| 94726 | <1% | 85 | $1K | |
| 58100 | <1% | 14 | $1K | |
| 73130 | <1% | 63 | $1K | |
| 0071A | <1% | 29 | $1K | |
| 94727 | <1% | 56 | $1K | |
| 99417 | Prolong home eval add 15m | <1% | 73 | $1K |
| 93294 | <1% | 98 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 84 | $1K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 17 | $956.21 |
| 73140 | <1% | 69 | $935.29 | |
| 93296 | <1% | 155 | $876.46 | |
| 93299 | <1% | 47 | $822.61 | |
| 98926 | <1% | 32 | $818.21 | |
| 0072A | <1% | 19 | $768.14 | |
| 87430 | <1% | 186 | $724.56 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 364 | $564.67 |
| 72081 | <1% | 28 | $524.00 | |
| 99219 | <1% | 21 | $502.07 | |
| 90715 | <1% | 12 | $496.92 | |
| 77073 | <1% | 16 | $463.35 | |
| Q4008 | Cast supplies, long arm cast, pediatric (0-10 years), fiberglass | <1% | 44 | $417.61 |
| 90633 | <1% | 59 | $368.33 | |
| Q4050 | Cast supplies, for unlisted types and materials of casts | <1% | 92 | $336.00 |
| 90658 | <1% | 30 | $320.40 | |
| 99406 | <1% | 38 | $312.41 | |
| 96161 | <1% | 116 | $294.86 | |
| 93971 | <1% | 17 | $294.63 | |
| 93295 | <1% | 12 | $292.05 | |
| G0008 | Administration of influenza virus vaccine | <1% | 793 | $273.60 |
| 73100 | <1% | 13 | $261.02 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 15 | $253.91 |
| 90647 | <1% | 228 | $248.62 | |
| 36416 | <1% | 1,963 | $228.72 | |
| 99283 | Emergency room visit (moderate) | <1% | 18 | $226.57 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 28 | $209.86 |
| 90723 | <1% | 163 | $207.94 | |
| 95816 | <1% | 15 | $206.21 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 51 | $200.39 |
| 90680 | <1% | 193 | $187.38 | |
| 82962 | <1% | 297 | $160.16 | |
| 3074F | <1% | 12,556 | $148.54 | |
| 99000 | <1% | 2,914 | $135.72 | |
| 90694 | <1% | 13 | $134.48 | |
| 3078F | <1% | 10,146 | $123.85 | |
| 90698 | <1% | 28 | $106.18 | |
| 84703 | <1% | 16 | $87.41 | |
| 94760 | <1% | 126 | $42.30 | |
| 3079F | <1% | 1,451 | $34.35 | |
| 3044F | <1% | 773 | $27.01 | |
| 82270 | <1% | 37 | $25.09 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 379 | $14.00 |
| 3062F | <1% | 328 | $13.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 23 | $10.75 |
| 3075F | <1% | 167 | $6.01 | |
| 3077F | <1% | 83 | $2.00 | |
| 90656 | <1% | 103 | $0.42 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 13,916 | $0.00 |
| 1036F | 0% | 3,412 | $0.00 | |
| 3017F | 0% | 531 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 67 | $0.00 |
| 91303 | 0% | 17 | $0.00 | |
| 3061F | 0% | 26 | $0.00 | |
| 1101F | 0% | 25 | $0.00 | |
| A4590 | Special casting material (e.g., fiberglass) | 0% | 17 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 13 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 2,071 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 13,063 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 59 | $0.00 |
| 4004F | 0% | 69 | $0.00 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 153 | $0.00 |
| 77003 | 0% | 62 | $0.00 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 134 | $0.00 |
| 4040F | 0% | 30 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHERZOG, CHRISTOPHER (CHIEF OPERATING OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Specialty Care of Practice Associates,pa | Morristown, NJ | $19K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.